Retatrutide is a triple agonist of the GIP, GLP-1, and glucagon receptors that is currently in development
Development of potassium effects on ion concentrations and indicator spaces in rat brain-cortex slices during postnatal ontogenesis
[PMID: 1560007] PubMed record related to this compound for laboratory literature review
Samiec, Paula S, Carolyn Drews-Botsch, Elaine W Flagg, Joanne C Kurtz, Paul Sternberg, Robyn L Reed, et Dean P Jones
As women, especially those aged 40 and above, experience a decline in natural growth hormone levels, their metabolism tends to slow down, leading to increased fat storage
More serious side effects, although rare, can include allergic reactions, chest pain, severe dizziness, or numbness in extremities